Search / Trial NCT00000370

Treatment of Social Phobia

Launched by BOSTON UNIVERSITY CHARLES RIVER CAMPUS · Nov 2, 1999

Trial Information

Current as of October 18, 2024

Completed

Keywords

Cognitive Therapy Cost Of Illness Female Human Male Phobic Disorders Phobic Disorders *Therapy Phobic Disorders Pathology

Description

The primary goal of the present study is to identify the mediators and moderators of change in the treatment of social phobia and, in so doing suggest a common mechanism of action for all brief psychosocial interventions. Perceived self-efficacy of social behavior, negative cognitive appraisal (estimated social costs), and perceived emotional control will be considered as potential mediators; avoidant personality disorder and the generalized subtype of social phobia will be considered as potential predictors for poor treatment outcome. Social phobia is a very prevalent and debilitating dis...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • -
  • Patients must have:
  • Social phobia with public speaking anxiety.

About Boston University Charles River Campus

Boston University Charles River Campus is a prominent academic institution dedicated to advancing health and science through innovative research and education. As a sponsor of clinical trials, the campus leverages its extensive resources and interdisciplinary expertise to facilitate groundbreaking studies that aim to improve patient outcomes and contribute to the understanding of various medical conditions. With a commitment to ethical research practices and collaboration with healthcare professionals, Boston University Charles River Campus plays a vital role in translating scientific discoveries into clinical applications that benefit communities locally and globally.

Locations

Boston, Massachusetts, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0